CHO DANG PHARM. CO., LTD.;CHO DANG PHARM. CO.; LTD.;초당약품공업 주식회사
发明人:
KIM, Nak Doo,김낙두
申请号：
KRKR2013/000820
公开号：
WO2013/122344A1
申请日:
2013.02.01
申请国别(地区):
KR
年份:
2013
代理人:
摘要：
The present invention relates to a pharmaceutical composition containing, as active ingredients, epitulipinolide and costunolide extracted from the bark of Liriodendron tulipifera. More specifically, the present invention relates to a pharmaceutical composition for treating the gastrointestinal tract, the composition containing, as active ingredients, epitulipinolide and costunolide, which are the active ingredients of the extract from the bark of Liriodendron tulipifera, and to the use thereof as a therapeutic agent for gastrointestinal diseases.La présente invention concerne une composition pharmaceutique contenant, en tant qu'ingrédients actifs, de l'épitulipinolide et du costunolide extraits de l'écorce de Liriodendron tulipifera. De manière plus spécifique, la présente invention porte sur une composition pharmaceutique utile pour traiter le tube digestif, la composition contenant, en tant qu'ingrédients actifs, de l'épitulipinolide et du costunolide, qui sont les ingrédients actifs extraits de l'écorce de Liriodendron tulipifera, et sur son utilisation en tant qu'agent thérapeutique pour les maladies gastro-intestinales.본 발명은 백합나무 수피에서 추출된 에피튜리피노라이드(Epitulipinolide) 및 코스튜노라이드(Costunolide)를 유효성분으로 함유한 약학적 조성물에 관한 것이다. 더욱 상세하게는 백합나무 수피 추출물의 활성 성분인 에피튜리피노라이드 및 코스튜노라이드를 유효성분으로 함유하는 위장관 치료용 의약 조성물 및 이의 위장질환 치료제로서의 용도에 관한 것이다.
